» Articles » PMID: 32599262

Chronic and Acute Arsenic Exposure Enhance EGFR Expression Via Distinct Molecular Mechanisms

Overview
Specialty Toxicology
Date 2020 Jun 30
PMID 32599262
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The impacts of acute arsenic exposure (i.e. vomiting, diarrhea, and renal failure) are distinct from those brought about by sustained, low level exposure from environmental sources or drinking of contaminated well water. Chronic arsenic exposure is a risk factor for the development of pulmonary diseases, including lung cancer. How arsenic exposure leads to pulmonary disease is not fully understood. Both acute versus chronic arsenic exposure increase EGFR expression, but do so via distinct molecular mechanisms. BEAS-2B cells were exposed to either acute sodium arsenite (5 μM for 24 h) or chronic sodium arsenite (100 nM for 24 weeks). Cells treated with acute arsenic exhibited a decrease in viability, changes in morphology, and increased mRNA level of BTC. In contrast, during 24 weeks of arsenic exposure, the cells had increased EGFR expression and activity, and increased mRNA and protein levels of TGFα. Further, chronic arsenic treatment caused an increase in cell migration in the absence of exogenous ligand. Elevated TGFα and EGFR expression are features of many non-small cell lung cancers. We propose that lung epithelial cells chronically exposed to low level arsenic increases EGFR signaling via TGFα production to enhance ligand-independent cell migration.

Citing Articles

Anticancer Effects of Arsenic Compounds in Non-Small Cell Lung Cancer.

Konduri N, Thyagarajan A, Sahu R Dis Res. 2024; 4(2):87-96.

PMID: 39717738 PMC: 11666069. DOI: 10.54457/dr.202402003.


Chronic arsenic exposure suppresses proteasomal and autophagic protein degradation.

Augenstein I, Nail A, Ferragut Cardoso A, States J, Banerjee M Environ Toxicol Pharmacol. 2024; 107:104398.

PMID: 38403142 PMC: 11465505. DOI: 10.1016/j.etap.2024.104398.


Effect of Long-Term Low-Dose Arsenic Exposure on DNA Methylation and Gene Expression in Human Liver Cells.

Stosser S, Lumpp T, Fischer F, Gunesch S, Schumacher P, Hartwig A Int J Mol Sci. 2023; 24(20).

PMID: 37894918 PMC: 10607230. DOI: 10.3390/ijms242015238.


Protective effects of zingerone against sodium arsenite-induced lung toxicity: A multi-biomarker approach.

Simsek H, Kucukler S, Gur C, Ileriturk M, Aygormez S, Kandemir F Iran J Basic Med Sci. 2023; 26(9):1098-1106.

PMID: 37605724 PMC: 10440130. DOI: 10.22038/IJBMS.2023.71905.15623.


Arsenic and cancer: Evidence and mechanisms.

Speer R, Zhou X, Volk L, Liu K, Hudson L Adv Pharmacol. 2023; 96:151-202.

PMID: 36858772 PMC: 10860672. DOI: 10.1016/bs.apha.2022.08.001.


References
1.
Stueckle T, Lu Y, Davis M, Wang L, Jiang B, Holaskova I . Chronic occupational exposure to arsenic induces carcinogenic gene signaling networks and neoplastic transformation in human lung epithelial cells. Toxicol Appl Pharmacol. 2012; 261(2):204-16. PMC: 3358533. DOI: 10.1016/j.taap.2012.04.003. View

2.
Putnam E, Yen N, Gallick G, Steck P, Fang K, Akpakip B . Autocrine growth stimulation by transforming growth factor-alpha in human non-small cell lung cancer. Surg Oncol. 1992; 1(1):49-60. DOI: 10.1016/0960-7404(92)90056-q. View

3.
Wang Z, Yang J, Fisher T, Xiao H, Jiang Y, Yang C . Akt activation is responsible for enhanced migratory and invasive behavior of arsenic-transformed human bronchial epithelial cells. Environ Health Perspect. 2011; 120(1):92-7. PMC: 3261952. DOI: 10.1289/ehp.1104061. View

4.
Martinazzi M, Crivelli F, Zampatti C, Martinazzi S . Epidermal growth factor receptor immunohistochemistry in different histological types of infiltrating breast carcinoma. J Clin Pathol. 1993; 46(11):1009-10. PMC: 501683. DOI: 10.1136/jcp.46.11.1009. View

5.
Lee H, Seo A, Kim E, Jang M, Kim Y, Kim J . Prognostic and predictive values of EGFR overexpression and EGFR copy number alteration in HER2-positive breast cancer. Br J Cancer. 2014; 112(1):103-11. PMC: 4453607. DOI: 10.1038/bjc.2014.556. View